EMA ‘Yes’ For Pegfilgrastim Biosimilars Spells End For Neulasta’s EU Stronghold

 
• By Neena Brizmohun
  
SC1807_Knight_1039720336_1200.jpg
Amgen's EU pegfilgrastim stronghold faces biosimilar attack • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip